Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
Farmers Insurance
Cerilliant
McKinsey
Johnson and Johnson
US Department of Justice
Cipla
Fuji

Generated: May 23, 2018

DrugPatentWatch Database Preview

GEMONIL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Gemonil patents expire, and what generic alternatives are available?

Gemonil is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in GEMONIL is metharbital. Additional details are available on the metharbital profile page.
Summary for GEMONIL
Drug patent expirations by year for GEMONIL
Synonyms for GEMONIL
02OS7K758T
1-Methyl-5,5-diethyl barbituric acid
1-Methylbarbital
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-1-methyl-
2,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-1-methyl-
5-24-09-00144 (Beilstein Handbook Reference)
5,5-Diaethyl-1-methyl-2,4,6-trioxo-hexahydropyrimidin
5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione
5,5-Diethyl-1-methyl-2,4,6-trioxo-hexahydropyrimidine
5,5-Diethyl-1-methyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5,5-Diethyl-1-methyl-2,4,6(1H,3H,5H)-pyrimidinetrione #
5,5-Diethyl-1-methylbarbituric acid
5,5-diethyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
5,5-diethyl-6-hydroxy-3-methyl-2,3,4,5-tetrahydropyrimidine-2,4-dione
50-11-3
AC1L1HES
AKOS006239548
AN 23
Barbituric acid, 5,5-diethyl-1-methyl-
Barbituric acid,5-diethyl-1-methyl-
BRN 0184688
CAS-50-11-3
CHEBI:31827
CHEMBL450
CTK6D0159
D01382
D02OZY
DB00463
DR000303
DSSTox_CID_3280
DSSTox_GSID_23280
DSSTox_RID_76955
DTXSID6023280
EINECS 200-011-2
Endiemal
Endiemalum
FT-0692647
FWJKNZONDWOGMI-UHFFFAOYSA-N
Gemonal
Gemonil (TN)
Gemonit
GTPL7230
HE345900
LS-24178
MCULE-9702939099
Metabarbital
Metarbital
Metarbital [INN-Spanish]
Metarbitale
Metarbitale [DCIT]
Methabarbital
Methabarbitone
metharbital
Metharbital (JAN/INN)
Metharbital [INN:JAN]
Metharbital [USP:INN:BAN:JAN]
Metharbital 1.0 mg/ml in Methanol
Metharbitalum
Metharbitalum [INN-Latin]
Metharbitone
Metharbutal
Methylbarbital
N-Methylbarbital
NCGC00181148-01
NSC 27156
NSC-27156
NSC27156
Sch 412
SCHEMBL78867
Tox21_112752
UNII-02OS7K758T
WLN: T6VMVNV FHJ D1 F2 F2
Z2205958937
ZINC5508997

US Patents and Regulatory Information for GEMONIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie GEMONIL metharbital TABLET;ORAL 008322-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Moodys
Julphar
Cantor Fitzgerald
Chinese Patent Office
Covington
Colorcon
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.